Several studies have shown that the absence of TPMT activity may be associated with increased risk for drug-related toxicity of patients, including myelosuppression, hepatotoxicity, and pancreatitis (Meggitt and Reynolds, 2001; Gisbert and Gomollon, 2008). Here, TPMT is linked to pancreatitis.